T h e glutamate/aspartate transporter GLAST-1 is expressed in bone in vivo and also exists as a splice variant (GLAST-la) in which exon 3 is excluded.
Introduction
T h e notion that glutamate signalling might be involved in bone cell communication was first proposed by Mason et al. [l] following the dis-covery that the glutamate/aspartate transporter GLAST-1 (also known as the excitatory amino acid transporter, or EAAT-1) was down-regulated in osteocytes in response to osteogenic mechanical stimuli [l] . It has since been demonstrated that osteoblasts express functional glutamate receptors [2, 3] and that specific inhibition with antagonists of the ionotropic N-methyl-D-aspartate (NMDA) receptor reduce osteoblast differentiation and activity [4] . In the central nervous system (CNS) GLAST-1 is expressed in the plasma membrane of glial cells where it removes extracellular glutamate, released as a neurotransmitter into the synapse, in order to terminate excitatory signals and prevent neurotoxicity. This has led us to the hypothesis that GLAST-1 may operate similarly in bone cells, modulating osteogenic glutamate signals by regulating extracellular glutamate concentrations.
A splice variant of GLAST-1, called GLAST-la, is also expressed in bone [ 5 ] .
GLAST-1 a retains the glutamate-binding domain but has lost parts of the first and second transmembrane domains, as well as the first extracellular loop, and is likely to assemble differently within the plasma membrane [S]. We propose that this variant may also contribute to the regulation of extracellular glutamate concentrations in bone.
We have investigated the effect of extracellular glutamate concentration on the level and pattern of GLAST-1 and G L A S T -l a expression since, in the CNS, glutamate increases GLAST-1 expression and trafficking to the cell surface of astrocytes [6]. Transfection of MLO-Y4 cells with green fluorescent protein (GFP)-tagged GLAST-1 and GLAST-1 a demonstrated that GLAST-1 localized to the plasma membrane whereas GLAST-1 a expression appeared to be internalized, possibly within vesicles surrounding the nucleus. Variation in extracellular glutamate concentration caused a redistribution in GLAST-1 expression and altered the level of expression of G L A S T -l a mRNA relative to GLAST-1. Our data show that GLAST-1 is expressed in the plasma membrane of osteocytes, where its distribution and level of expression varies in response to extracellular glutamate concentrations. This is consistent with its glutamate transport function which, in the CNS, is critical in the co-ordinated control of glutamate signalling.
Materials and methods

RNA extraction
Rat tibiae (minus marrow) were snap-frozen in liquid nitrogen and powdered (B. Braun Biotech Dismembrator) in 1 ml of TrizolB reagent (Gibco BRL). Total RNA was extracted from powdered bone and cell cultures using Trizol@ following the manufacturer's instructions before purification with Tack resin (Biogenesis). Genomic DNA was removed using RQ1 DNase with RNasin@ ribonuclease inhibitor at 37 "C for 15 min (Promega). RNA was re-extracted in 500 p1 of TrizoP.
Reverse transcriptase (RT)-PCR and Southern blotting
Oligo (dT,,)-primed RNA was reverse transcribed using SuperscriptTM I1 (Gibco BRL) according to the manufacturer's instructions. cDNA samples were amplified by PCR using primers to exons 2 (S'-TCCACCAGTCACAGAATCAGA-3') and 4 (5'-GAGTCAGAAGAAAGGGCAAAC-3') of
GLAST-1 under standard conditions [3 mM
MgCl,, 150 nM of each primer, 1 unit of Tuq polymerase (Promega), 58 "C annealing, 40 cycles].
PCR products were resolved on 1 yo agarose gels and either photographed under UV light or blotted on to nylon membrane (Hybond-N; Amersham Biosciences). After UV cross-linking, blots were hybridized to a digoxigenin-labelled ( D I G high prime; Roche) GLAST-1 probe at 42°C overnight ( D I G easy hyb; Roche). After washing (2xSSC/O.l0/, SDS, 68°C; where 1 x S S C is 0.15 M NaC1/0.015 M sodium citrate), probes were visualized by enhanced chemiluminescence (Roche).
Transfection of MLO-Y4 cells with GLAST-I-GFP and GLAST-Ia-GFP
The open reading frames of each GLAST variant were cloned into the pD2EGFP-N1 mammalian expression vector (Clontech). GLAST variant vectors or the empty G F P vector were transfected into MLO-Y4 cells (Effectene transfection reagent ; Qiagen) according to the manufacturer's protocol. Briefly, 50 ng of purified plasmid was complexed with Effectene 
Results and discussion
GLAST-I a mRNA is expressed at high levels in osteocytes and is responsive to extracellular glutamate in SaOS-2 osteoblast-like cells GLAST-la mRNA, in which exon 3 is excluded, is expressed at lower levels than GLAST-1 since it is not normally visible after RT-PCR with primers that span exons 2 4 . T o quantify the ratio of GLAST-la/GLAST-1 mRNA we hybridized products with GLAST-1 probes. Figure I (a) shows that the expression of G L A S T -l a mRNA, relative to GLAST-1, is greater in R/ILO-Y4 osteocytes than in the human osteoblast-like cell line SaOS-2 or bone. However, treatment of SaOS-2 cells with various glutamate concentrations for 5 days revealed an up-regulation of G L A S T -l a mRKA, relative to GLAST-1 mRNA, at 1 0 p M glutamate, indicating that the expression levels of each variant may be responsive to extracellular glutamate levels in osteoblasts (Figure 1 b) . Since GLAST-1 -expressing astrocytes that surround synapses increase their cellsurface expression of G L A S T -1 on administration of glutamate [6] we also investigated the effect of glutamate on the distribution of the G L A S T isoforms in osteocytes.
Southern blots of G L A S T exon 2 4 PCR
GLAST-I is targeted to the plasma membrane of MLO-Y4 osteocytes and relocalizes in response to extracellular glutamate MLO-Y4 cells transfected with expression vectors encoding recombinant GLAST-1-GFP and G L A S T -1 a-GFP were examined by scanning laser confocal microscopy to reveal the distribution of these glutamate transporter isoforms. When the cells were cultured under normal con- (Figure 2a ), whereas the low extracellular glutamate concentration caused the GLAST-1 expression to localize internally close to the nucleus of the cell (Figure 2b ). Interestingly, this internal vesicular distribution close to the nucleus was also observed in GLAST-la-GFP-transfected 24 h cultures grown under normal conditions ( Figure  2c ). We were unable to determine the effect of glutamate concentration on GLAST-la distribution due to low transfection efficiencies. These experiments show that GLAST-1 is expressed in the plasma membrane of osteocytes and redistributes between the periphery and cytoplasm of the cell in response to extracellular glutamate. This observation is consistent with the localization and trafficking of GLAST-1 in astrocytes, which has been speculated to regulate extracellular glutamate signalling in the CNS [6]. The localization of the GLAST-la isoform is different to that of GLAST-1 in osteocytes, which may reflect an alternative function for this protein in these cells or a different glutamate concentration to which it responds. In conclusion, our data show that GLAST-1 and GLAST-1 a expression levels are regulated by extracellular glutamate and that the cell-surface expression of GLAST-1 is increased in response to high glutamate concentrations in osteocytes. This supports our hypothesis that the GLAST isoforms are important in modulating glutamatemediated osteogenesis.
